Covaxin Phase 2, 3 Clinical Trials For 2-18 Age Group Cleared

 

New Delhi:

Clinical trials of Covaxin for youngsters from two and 18 years has been cleared by the Drugs Controller General of India (DCGI).

Covaxin maker Bharat Biotech has stated the trial might be carried out on “525 healthy volunteers”.

According to a authorities assertion, the drug regulator accepted the advice of an professional committee on vaccines.

The trial entails two vaccine doses injected at day 0 and day 28.